haloperidol and xe 991, anthracenone

haloperidol has been researched along with xe 991, anthracenone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ebbesen, C; Hansen, HH; Mathiesen, C; Mikkelsen, JD; Rønn, LC; Scuvée-Moreau, J; Seutin, V; Waroux, O; Weikop, P	1

Other Studies

1 other study(ies) available for haloperidol and xe 991, anthracenone

Article	Year
The KCNQ channel opener retigabine inhibits the activity of mesencephalic dopaminergic systems of the rat. The Journal of pharmacology and experimental therapeutics, 2006, Volume: 318, Issue:3 Topics: Animals; Anthracenes; Carbamates; Dopamine; Dopamine Antagonists; Haloperidol; KCNQ Potassium Channels; Male; Mesencephalon; Phenylenediamines; Phosphorylation; Protein Subunits; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Substantia Nigra; Tyrosine 3-Monooxygenase; Ventral Tegmental Area	2006

Article

Year

The KCNQ channel opener retigabine inhibits the activity of mesencephalic dopaminergic systems of the rat.

The Journal of pharmacology and experimental therapeutics, 2006, Volume: 318, Issue:3

Topics: Animals; Anthracenes; Carbamates; Dopamine; Dopamine Antagonists; Haloperidol; KCNQ Potassium Channels; Male; Mesencephalon; Phenylenediamines; Phosphorylation; Protein Subunits; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Substantia Nigra; Tyrosine 3-Monooxygenase; Ventral Tegmental Area

2006